MS

Mudugu Soumya

Active Director Director DIN 11500140
DIN 11500140 First appointment Feb 2026 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2026
Shareholding value Locked Premium profile

About Mudugu Soumya

Mudugu Soumya has experience in corporate governance. Holds Director role. Currently with 1 company, including Nacro Biotech Limited. Engaged in Technology. Contributes to corporate operations.

DIN 11500140
Primary Designation Director
First Appointment 02 Feb 2026
Oldest Company Age Not Provided

Current companies

Company Designation Appointment Founded Status
Nacro Biotech Limited U20121TS2026PLC210593
Director 02 Feb 2026 2026 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nacro Biotech Limited
Premium access

Shareholding and investment profile for Mudugu Soumya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mudugu Soumya

Mudugu Soumya has experience in corporate governance. Holds Director role. Currently with 1 company, including Nacro Biotech Limited. Engaged in Technology. Contributes to corporate operations.

Mudugu Soumya is associated with 1 company as Director.

Mudugu Soumya has expertise in Technology.

Mudugu Soumya has extensive experience in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available